RSS feed

Publications by Zinajda Zolic-Karlsson

6 publications found

Original articles

Gottschlich KN, Zolic-Karlsson Z, Aas E, Kvistad SAS, Bø L, Torkildsen Ø, Lehmann AK (2024)
Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis
Mult Scler Relat Disord, 84, 105507
DOI 10.1016/j.msard.2024.105507, PubMed 38412758

Killingmo RM, Storheim K, van der Windt D, Zolic-Karlsson Z, Vigdal ØN, Kretz L, Småstuen MC, Grotle M (2022)
Healthcare utilization and related costs among older people seeking primary care due to back pain: findings from the BACE-N cohort study
BMJ Open, 12 (6), e057778
DOI 10.1136/bmjopen-2021-057778, PubMed 35725262

Killingmo RM, Chiarotto A, van der Windt DA, Storheim K, Bierma-Zeinstra SMA, Småstuen MC, Zolic-Karlsson Z, Vigdal ØN, Koes BW, Grotle M (2022)
Modifiable prognostic factors of high costs related to healthcare utilization among older people seeking primary care due to back pain: an identification and replication study
BMC Health Serv Res, 22 (1), 793
DOI 10.1186/s12913-022-08180-2, PubMed 35717179

Bjørnelv GMW, Zolic-Karlsson Z, Dueland S, Line PD, Aas E (2022)
Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases
Br J Surg, 109 (6), 483-485
DOI 10.1093/bjs/znac022, PubMed 35576387

Hassellund S, Zolic-Karlsson Z, Williksen JH, Husby T, Madsen JE, Frihagen F (2021)
Surgical treatment is not cost-effective compared to nonoperative treatment for displaced distal radius fractures in patients 65 years and over
Bone Jt Open, 2 (12), 1027-1034
DOI 10.1302/2633-1462.212.BJO-2021-0108.R1, PubMed 34856811

Grotle M, Bråten LC, Brox JI, Espeland A, Zolic-Karlsson Z, Munk Killingmo R, Tingulstad A, Grøvle L, Froholdt A, Kristoffersen PM, Wigemyr M, van Tulder MW, Storheim K, Zwart JA, AIM-study group (2020)
Cost-utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo-controlled trial in Norway (the AIM study)
BMJ Open, 10 (6), e035461
DOI 10.1136/bmjopen-2019-035461, PubMed 32546490